A group of interdisciplinary researchers received more than $3.3 million in grants for their research on networks within the autonomic nervous system and therapies that may lead to new treatments for heart attack and sleep apnea.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) has received a $700,000 grant from the Commonwealth of Virginia to implement an innovative educational project in the life sciences and expand regional job opportunities for students in the Governor’s Health...
SMHS is embarking on a strategic planning process, with the GW MFA, that will guide the combined goals of the SMHS/GW MFA for the first several years of the post-pandemic academic medical enterprise.
As news emerges that COVID-19 vaccine trials from U.S. pharmaceutical corporations Pfizer and Moderna are showing, in preliminary data, high-efficacy rates, a new question is being asked: What comes next?
A recent study by GW physicians on the severity of acute respiratory viral adverse events related to antirheumatic disease therapies found that some therapies may be associated with increased respiratory viral events while others don’t show increased frequency.